PHVS Earnings Date & History
Pharvaris NV (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:06 PM ET
Pharvaris NV
Pharmaceuticals
- Next earnings date
- Wednesday, August 19, 2026
- Reporting session
- After Close
- EPS estimate
- $-0.67
- Revenue estimate
- $0
PHVS earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Tuesday, May 12, 2026 | Q1 2026 | $-0.73 | $-0.59 | +18.8% | $0 |
| Thursday, April 2, 2026 | Q4 2025 | $-0.63 | $-0.72 | -13.7% | $0 |
| Wednesday, November 12, 2025 | Q3 2025 | $-0.68 | $-0.60 | +12.3% | $0 |
| Tuesday, August 12, 2025 | Q2 2025 | $-0.79 | $-0.83 | -5.6% | $0 |
What the market is watching in PHVS's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next PHVS earnings date?
- Pharvaris NV is scheduled to report on Wednesday, August 19, 2026 (After Close). Dates can change until the company confirms them.
- Does PHVS report before or after the market?
- The next report is scheduled after close.
- What EPS is expected for PHVS?
- Consensus EPS for the upcoming quarter is $-0.67, on revenue of $0.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
PHVS earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.